Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 4,899.00
-132.10 (-2.63%)
Aug 1, 2025, 3:29 PM IST
Smartsheet Market Cap
Alkem Laboratories has a market cap or net worth of 585.75 billion as of August 1, 2025. Its market cap has decreased by -7.51% in one year.
Market Cap
585.75B
Enterprise Value
563.00B
Revenue
129.65B
Ranking
n/a
PE Ratio
27.05
Stock Price
$4,899.00
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 585.75B, an increase of 254.56%. That is a compound annual growth rate of 14.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 585.75B | -13.04% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | 349.87B | 45.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,094.94B |
| Divi's Laboratories | 1,750.90B |
| Cipla | 1,255.73B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,062.98B |
| Zydus Lifesciences | 975.85B |
| Aurobindo Pharma | 672.57B |
| Fortis Healthcare | 647.34B |